Search Within

Andrew C Koff

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (9)
  2. GSK Faculty (9)
  3. Hematologic Malignancies, Division of (9)
  4. Molecular Biology Program Faculty (9)
  5. Sloan Kettering Institute Faculty (9)
  6. Department of Pathology and Laboratory Medicine (5)

More Groups

People
  1. Stephen Nimer (5)
  2. Cristina Antonescu (4)
  3. Goro Sashida (4)
  4. Li-Xuan Qin (4)
  5. Mark Dickson (4)
  6. Mrinal Gounder (4)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2019 (1)
  4. 2016 (1)
  5. 2009 (2)
  6. 2007 (1)

More Years

Publications
  1. Blood (2)
  2. Cell Cycle (1)
  3. Cell Stem Cell (1)
  4. Clinical Cancer Research (1)
  5. JAMA Oncology (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (2)
  2. American Association for Cancer Research (1)
  3. American Medical Association (1)
  4. American Society for Microbiology (1)
  5. American Society of Clinical Oncology (1)
  6. Cell Press (1)

More Publishers

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-MeĢrida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
    Journal Article

    D'Angelo, S. P.; Richards, A. L.; Conley, A. P.; Woo, H. J.; Dickson, M. A.; Gounder, M.; Kelly, C.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Phase 2 study of the CDK4 inhibitor abemaciclib in dedifferentiated liposarcoma
    Meeting Abstract

    Dickson, M. A.; Koff, A.; D'Angelo, S. P.; Gounder, M. M.; Keohan, M. L.; Kelly, C. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor palbociclib: A phase 2 clinical trial
    Journal Article

    Dickson, M. A.; Schwartz, G. K.; Louise Keohan, M.; D'Angelo, S. P.; Gounder, M. M.; Chi, P.; Antonescu, C. R.; Landa, J.; Qin, L. X.; Crago, A. M.; more...
    JAMA Oncology (2016)

    Fulltext@MSK | Save
  • p53 Regulates Hematopoietic Stem Cell Quiescence
    Journal Article

    Liu, Y.; Elf, S. E.; Miyata, Y.; Sashida, G.; Huang, G.; Di Giandomenico, S.; Lee, J. M.; Deblasio, A.; Menendez, S.; Antipin, J.; more...
    Cell Stem Cell (2009)

    Fulltext@MSK | Save
  • The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
    Journal Article

    Liu, Y.; Elf, S. E.; Asai, T.; Miyata, Y.; Sashida, G.; Huang, G.; Di Giandomenico, S.; Koff, A.; Nimer, S. D.
    Cell Cycle (2009)

    Fulltext@MSK | Save
  • Regulation of hematopoietic stem cell quiescence - A novel role for p53
    Meeting Abstract

    Liu, Y.; Elf, S. E.; Miyata, Y.; Sashida, G.; Deblasio, A.; Koff, A.; Nimer, S. D.
    Blood (2007)

    Fulltext@MSK | Save
  • Genetic uncoupling of the regulation of hematopoietic stem cell quiescence and self-renewal
    Meeting Abstract

    Liu, Y.; Miyata, Y.; Sashida, G.; Deblasio, A.; Liu, Y. H.; Koff, A.; Nimer, S. D.
    Blood (2006)

    Fulltext@MSK | Save
  • The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2
    Journal Article

    Liu, Y.; Hedvat, C. V.; Mao, S.; Zhu, X. H.; Yao, J.; Nguyen, H.; Koff, A.; Nimer, S. D.
    Molecular and Cellular Biology (2006)

    Fulltext@MSK | Save